– | Third Quarter Revenue of $58.7 Million, an Increase of 33% Year-Over-Year |
– | Issues Revenue Guidance of $62.0 Million - $63.0 Million for the Fourth Quarter Fiscal 2019 |
– | Updates Revenue Guidance for Fiscal 2019 to $227 Million - $228 Million |
• | Revenue of $58.7 million, a 33% increase as compared to the $44.3 million reported in third quarter fiscal 2018. The revenue increase was primarily due to the continued growth of our customer base and higher revenue from existing customers, primarily due to expanded subscriptions. |
• | Gross Profit of $43.9 million, a 34% increase as compared to the $32.7 million reported in third quarter fiscal 2018. Gross margin of 74.7% as compared to the 73.7% reported in third quarter fiscal 2018. |
• | Net Loss and Non-GAAP Net Loss: |
• | Net loss of $24.8 million increased 45% as compared to the $17.1 million net loss in third quarter fiscal 2018. The increased loss was driven by increased operating expenses, primarily in sales and marketing associated with increased headcount and higher field marketing costs, including ONWARD18, incurred due to efforts to acquire new customers. |
• | Non-GAAP net loss of $11.8 million increased 6% as compared to the $11.1 million non-GAAP net loss in the third quarter fiscal 2018. The increase was due to the same factors that drove the higher net loss. |
• | Net Loss Per Share and Non-GAAP Net Loss Per Share: |
• | Net loss per share of $0.25 in the third quarter of fiscal 2019 compared to a net loss per share of $0.19 in the third quarter of fiscal 2018. |
• | Non-GAAP net loss per share of $0.12 in the third quarter of fiscal 2019 compared to a non-GAAP net loss per share of $0.12 in the third quarter of fiscal 2018. |
• | Net loss per share and non-GAAP net loss per share were based on 99.6 million weighted-average shares outstanding for the third quarter of fiscal 2019 and 90.4 million weighted-average shares outstanding for the third quarter of fiscal 2018. |
• | Balance Sheet: Cash, cash equivalents and marketable securities of $107.0 million as of October 31, 2018. |
• | Cash Flow: Net cash used in operating activities for the third quarter of fiscal 2019 was $22.6 million as compared to net cash used in operating activities of $16.4 million in the same period in fiscal 2018. The decrease in the current period reflects, in part, the earlier timing of ONWARD18, as the previous event had occurred in the fourth quarter of fiscal 2018. Net cash used in operating activities over the first nine months of fiscal 2019 was $25.6 million as compared to net cash used in operating activities of $30.3 million in the same period in fiscal 2018. The improvement over fiscal 2018 reflects a greater source of cash from working capital. |
• | Unveiled several new services and features at ONWARD18, including: Yext Brain, an AI-ready data structure that allows businesses to define any fact and designate relationships among those facts; Yext Think, an answers engine powering experiences on a business's own website with direct answers; and AI Pages, which creates smart landing pages for anything stored in Yext Brain. |
• | Announced a global integration with Snapchat, putting businesses in control of the facts about them on one of the world's most active social platforms. With this integration, the information consumers see about businesses using Yext in Snapchat's Context Cards and Organic Venue Geofilters will be powered directly by the Yext Brain. |
• | Issued the Fall '18 Release, providing new services and features, including: a self-service option for Yext Pages, giving businesses a fast and easy way to generate smart, transactional, AI-ready pages with just a few clicks; and updates to intelligent review response, making it easier for businesses to respond to reviews and see analytics on review response processes. |
• | Expanded the capabilities of the Yext App Directory through additional integrations with Tableau, a business intelligence and analytics platform. The Yext App Directory allows customers to connect the digital knowledge they are managing within Yext to other software systems used across the enterprise, such as Salesforce, HubSpot, Zendesk, and StoreForce. |
• | Named a Great Place to Work on Fortune's list of the Top 100 Medium-Size Workplaces. |
• | Fourth Quarter Fiscal 2019 Outlook: |
• | Revenue is projected to be $62.0 million to $63.0 million. |
• | Non-GAAP net loss per share is projected to be $0.09 to $0.10, which assumes 101.7 million weighted-average shares outstanding. |
• | Full Year Fiscal 2019 Outlook: |
• | Revenue is projected to be $227 million to $228 million. |
• | Non-GAAP net loss per share is projected to be $0.41 to $0.42. This assumes 98.5 million weighted-average shares outstanding. |
October 31, 2018 | January 31, 2018 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 28,337 | $ | 34,367 | |||
Marketable securities | 78,697 | 83,974 | |||||
Accounts receivable, net of allowances of $148 and $231, respectively | 34,446 | 44,656 | |||||
Prepaid expenses and other current assets | 10,687 | 7,703 | |||||
Deferred commissions, current | 10,948 | 9,342 | |||||
Total current assets | 163,115 | 180,042 | |||||
Property and equipment, net | 11,635 | 11,438 | |||||
Goodwill | 4,623 | 4,924 | |||||
Intangible assets, net | 2,064 | 2,761 | |||||
Other long term assets | 4,825 | 4,324 | |||||
Total assets | $ | 186,262 | $ | 203,489 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable, accrued expenses and other current liabilities | $ | 27,033 | $ | 27,416 | |||
Deferred revenue, current | 83,193 | 89,474 | |||||
Deferred rent, current | 1,472 | 1,288 | |||||
Total current liabilities | 111,698 | 118,178 | |||||
Deferred rent, non-current | 2,096 | 3,213 | |||||
Other long term liabilities | 598 | 645 | |||||
Total liabilities | 114,392 | 122,036 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Preferred stock, $0.001 par value per share; 50,000,000 shares authorized at October 31, 2018 and January 31, 2018; zero shares issued and outstanding at October 31, 2018 and January 31, 2018 | — | — | |||||
Common stock, $0.001 par value per share; 500,000,000 shares authorized at October 31, 2018 and January 31, 2018; 107,277,643 and 100,482,264 shares issued at October 31, 2018 and January 31, 2018, respectively; 100,772,309 and 93,976,930 shares outstanding at October 31, 2018 and January 31, 2018, respectively | 107 | 100 | |||||
Additional paid-in capital | 382,564 | 328,344 | |||||
Accumulated other comprehensive loss | (1,448 | ) | (1,636 | ) | |||
Accumulated deficit | (297,448 | ) | (233,450 | ) | |||
Treasury stock, at cost | (11,905 | ) | (11,905 | ) | |||
Total stockholders’ equity | 71,870 | 81,453 | |||||
Total liabilities and stockholders’ equity | $ | 186,262 | $ | 203,489 |
Three months ended October 31, | Nine months ended October 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Revenue | $ | 58,742 | $ | 44,332 | $ | 164,933 | $ | 122,181 | |||||||
Cost of revenue | 14,886 | 11,658 | 41,772 | 31,887 | |||||||||||
Gross profit | 43,856 | 32,674 | 123,161 | 90,294 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 45,669 | 32,756 | 122,869 | 91,891 | |||||||||||
Research and development | 9,158 | 6,958 | 26,870 | 18,437 | |||||||||||
General and administrative | 13,867 | 10,196 | 37,465 | 29,103 | |||||||||||
Total operating expenses | 68,694 | 49,910 | 187,204 | 139,431 | |||||||||||
Loss from operations | (24,838 | ) | (17,236 | ) | (64,043 | ) | (49,137 | ) | |||||||
Investment income | 350 | 419 | 1,113 | 741 | |||||||||||
Interest income (expense) | 74 | (104 | ) | (2 | ) | (274 | ) | ||||||||
Other expense, net | (194 | ) | (132 | ) | (583 | ) | (667 | ) | |||||||
Loss from operations before income taxes | (24,608 | ) | (17,053 | ) | (63,515 | ) | (49,337 | ) | |||||||
Provision for income taxes | (158 | ) | (9 | ) | (483 | ) | (230 | ) | |||||||
Net loss | $ | (24,766 | ) | $ | (17,062 | ) | $ | (63,998 | ) | $ | (49,567 | ) | |||
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.25 | ) | $ | (0.19 | ) | $ | (0.66 | ) | $ | (0.67 | ) | |||
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 99,628,479 | 90,353,608 | 97,387,544 | 73,992,705 | |||||||||||
Other comprehensive income (loss): | |||||||||||||||
Foreign currency translation adjustment | $ | 126 | $ | 53 | $ | 22 | $ | 410 | |||||||
Unrealized gain (loss) on marketable securities | 55 | (88 | ) | 166 | (148 | ) | |||||||||
Total comprehensive loss | $ | (24,585 | ) | $ | (17,097 | ) | $ | (63,810 | ) | $ | (49,305 | ) |
Nine months ended October 31, | |||||||
2018 | 2017 | ||||||
Operating activities: | |||||||
Net loss | $ | (63,998 | ) | $ | (49,567 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 5,028 | 3,751 | |||||
Provision for bad debts | 302 | 321 | |||||
Stock-based compensation expense | 31,943 | 15,002 | |||||
Change in fair value of convertible preferred stock warrant liability | — | 491 | |||||
Deferred income taxes | (54 | ) | (13 | ) | |||
Amortization of deferred financing costs | 98 | 105 | |||||
Amortization of premium on marketable securities | (61 | ) | 108 | ||||
Gain on sale of marketable securities | — | (1 | ) | ||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 9,352 | 3,629 | |||||
Prepaid expenses and other current assets | (3,325 | ) | (1,989 | ) | |||
Deferred commissions | (1,831 | ) | (1,152 | ) | |||
Other long term assets | (509 | ) | (161 | ) | |||
Accounts payable, accrued expenses and other current liabilities | 3,681 | (2,625 | ) | ||||
Deferred revenue | (5,298 | ) | 2,263 | ||||
Deferred rent | (910 | ) | (581 | ) | |||
Other long term liabilities | 2 | 89 | |||||
Net cash used in operating activities | (25,580 | ) | (30,330 | ) | |||
Investing activities: | |||||||
Purchases of marketable securities | (52,916 | ) | (106,155 | ) | |||
Maturities of marketable securities | 58,420 | 7,500 | |||||
Sales of marketable securities | — | 6,041 | |||||
Capital expenditures | (4,321 | ) | (2,747 | ) | |||
Net cash provided by (used in) investing activities | 1,183 | (95,361 | ) | ||||
Financing activities: | |||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | — | 123,527 | |||||
Payments of deferred offering costs | — | (4,263 | ) | ||||
Proceeds from exercise of stock options | 15,044 | 4,686 | |||||
Proceeds from exercise of warrants | — | 79 | |||||
Repayments on Revolving Line | — | (5,000 | ) | ||||
Payments of deferred financing costs | (159 | ) | (99 | ) | |||
Proceeds, net from employee stock purchase plan withholdings | 3,947 | 2,724 | |||||
Net cash provided by financing activities | 18,832 | 121,654 | |||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (465 | ) | 229 | ||||
Net decrease in cash, cash equivalents and restricted cash | (6,030 | ) | (3,808 | ) | |||
Cash, cash equivalents and restricted cash at beginning of period | 34,367 | 24,920 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 28,337 | $ | 21,112 |
(in thousands) | October 31, 2018 | October 31, 2017 | |||||
Cash and cash equivalents | $ | 28,337 | $ | 21,112 | |||
Restricted cash | — | — | |||||
Total cash, cash equivalents and restricted cash | $ | 28,337 | $ | 21,112 |
Three months ended October 31, 2018 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 14,886 | $ | (820 | ) | $ | 14,066 | ||||
Gross profit | $ | 43,856 | $ | (820 | ) | $ | 44,676 | ||||
Sales and marketing | $ | 45,669 | $ | (6,891 | ) | $ | 38,778 | ||||
Research and development | $ | 9,158 | $ | (2,369 | ) | $ | 6,789 | ||||
General and administrative | $ | 13,867 | $ | (2,842 | ) | $ | 11,025 | ||||
Loss from operations | $ | (24,838 | ) | $ | (12,922 | ) | $ | (11,916 | ) | ||
Net loss | $ | (24,766 | ) | $ | (12,922 | ) | $ | (11,844 | ) | ||
Net loss margin | (42 | )% | (22 | )% | (20 | )% |
Three months ended October 31, 2017 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 11,658 | $ | (461 | ) | $ | 11,197 | ||||
Gross profit | $ | 32,674 | $ | (461 | ) | $ | 33,135 | ||||
Sales and marketing | $ | 32,756 | $ | (2,741 | ) | $ | 30,015 | ||||
Research and development | $ | 6,958 | $ | (1,121 | ) | $ | 5,837 | ||||
General and administrative | $ | 10,196 | $ | (1,614 | ) | $ | 8,582 | ||||
Loss from operations | $ | (17,236 | ) | $ | (5,937 | ) | $ | (11,299 | ) | ||
Net loss | $ | (17,062 | ) | $ | (5,937 | ) | $ | (11,125 | ) | ||
Net loss margin | (38 | )% | (13 | )% | (25 | )% |
Nine months ended October 31, 2018 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 41,772 | $ | (2,032 | ) | $ | 39,740 | ||||
Gross profit | $ | 123,161 | $ | (2,032 | ) | $ | 125,193 | ||||
Sales and marketing | $ | 122,869 | $ | (16,330 | ) | $ | 106,539 | ||||
Research and development | $ | 26,870 | $ | (6,011 | ) | $ | 20,859 | ||||
General and administrative | $ | 37,465 | $ | (7,570 | ) | $ | 29,895 | ||||
Loss from operations | $ | (64,043 | ) | $ | (31,943 | ) | $ | (32,100 | ) | ||
Net loss | $ | (63,998 | ) | $ | (31,943 | ) | $ | (32,055 | ) | ||
Net loss margin | (39 | )% | (20 | )% | (19 | )% |
Nine months ended October 31, 2017 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 31,887 | $ | (947 | ) | $ | 30,940 | ||||
Gross profit | $ | 90,294 | $ | (947 | ) | $ | 91,241 | ||||
Sales and marketing | $ | 91,891 | $ | (7,477 | ) | $ | 84,414 | ||||
Research and development | $ | 18,437 | $ | (2,433 | ) | $ | 16,004 | ||||
General and administrative | $ | 29,103 | $ | (4,145 | ) | $ | 24,958 | ||||
Loss from operations | $ | (49,137 | ) | $ | (15,002 | ) | $ | (34,135 | ) | ||
Net loss | $ | (49,567 | ) | $ | (15,002 | ) | $ | (34,565 | ) | ||
Net loss margin | (41 | )% | (13 | )% | (28 | )% |
Three months ended October 31, | |||||||
2018 | 2017 | ||||||
Net loss | $ | (24,766 | ) | $ | (17,062 | ) | |
Stock-based compensation expense | 12,922 | 5,937 | |||||
Non-GAAP net loss | $ | (11,844 | ) | $ | (11,125 | ) | |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.25 | ) | $ | (0.19 | ) | |
Stock-based compensation expense per share | 0.13 | 0.07 | |||||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.12 | ) | $ | (0.12 | ) | |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 99,628,479 | 90,353,608 |
Nine months ended October 31, | |||||||
2018 | 2017 | ||||||
Net loss | $ | (63,998 | ) | $ | (49,567 | ) | |
Stock-based compensation expense | 31,943 | 15,002 | |||||
Non-GAAP net loss | $ | (32,055 | ) | $ | (34,565 | ) | |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.66 | ) | $ | (0.67 | ) | |
Stock-based compensation expense per share | 0.33 | 0.20 | |||||
Non-GAAP unweighted adjustment | — | 0.09 | |||||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.33 | ) | $ | (0.38 | ) | |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 97,387,544 | 73,992,705 | |||||
Non-GAAP unweighted adjustment | — | 16,002,736 | |||||
Non-GAAP number of shares outstanding in computing non-GAAP net loss per share attributable to common stockholders, basic and diluted | 97,387,544 | 89,995,441 |
Three months ended October 31, | |||||||
2018 | 2017 | ||||||
Net cash (used in) provided by: | |||||||
Net loss | $ | (24,766 | ) | $ | (17,062 | ) | |
Adjustments to net loss for non-cash items | 14,585 | 7,535 | |||||
Changes in operating assets and liabilities | (12,383 | ) | (6,854 | ) | |||
Operating activities | (22,564 | ) | (16,381 | ) | |||
Investing activities | (2,489 | ) | 971 | ||||
Financing activities | 6,347 | 3,692 | |||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (112 | ) | (49 | ) | |||
Net decrease in cash, cash equivalents and restricted cash | (18,818 | ) | (11,767 | ) | |||
Cash, cash equivalents and restricted cash at beginning of period | 47,155 | 32,879 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 28,337 | $ | 21,112 |